Voyager Life PLC - Half-year Report
Announcement provided by
Mendell Helium plc · MDH19/11/2021 07:00
Date: 19 November 2021
Voyager Life plc
("Voyager" or the "Company")
Unaudited Interim Results for the six months ended 30 September 2021
The unaudited interim results of Voyager Life plc ("Voyager" or the "Company") for the six months ended 30 September 2021 are presented below.
Highlights:
Operational:
· 32 formulated products and 90 total SKUs (stock keeping unit) available across the website and stores - Voyager products now sold from
· Voyager products will be listed by CLF, a leading wholesaler
· Products now stocked on The Range online marketplace with an agreement in place to be stocked by Thompson and Morgan
· Voyager's second store opened in
· VoyagerCBD.com retail website relaunched
Financial:
· Revenue from incorporation to 30 September 2021 of
· Cash balance as at 30 September 2021 of
· Monthly overheads of below
· Inventory of
This announcement contains inside information for the purposes of
Enquiries:
Voyager
Nick Tulloch +44 (0) 1738 505 130 and nick@voyagerlife.uk
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Liam Murray or Ludovico Lazzaretti +44 (0) 20 72130 880
Chairman's Statement
It is a pleasure to report Voyager's first interim results. It is just over one year since the Company was founded and in that short period we have grown to become a respected CBD company with a network of shops stocking our products from
We have been clear from the outset that we expect nothing less from ourselves than the highest standards of corporate governance and customer service and I am delighted to say that our rigorous approach is now showing results. With much of the first half of this calendar year focused on developing our product range, recent months have seen a rapid increase in customers stocking Voyager products as well as the opening of our own stores. Pleasingly, when presenting to new customers in person, our sales team more often than not secure a sales contract. Our re-branding over the summer has been positively received and our products are consistently popular.
During the period we also completed our IPO on Aquis Stock Exchange Growth Market which followed on from a heavily oversubscribed crowdfunding on Seedrs. Importantly the capital raised gave us the financial resources to expand our business and we still have well over two years' cash in the bank (irrespective of revenues), making Voyager, in our view, one of the more financially secure companies in our sector.
Voyager is in as strong a position at this stage and certainly as good as we could have hoped for when the Company was founded a year ago. Our achievements to date are testament to the entire team, all of whom have played a part in our journey to date. With such a solid platform in place, 2022 holds a great deal of excitement for us and I look forward to reporting our progress during the year.
Our latest investor presentation is available to download at https://voyagerlife.uk/investors/.
Eric Boyle
Chairman
19 November 2021
Chief Executive Officer's Review
At the time of our IPO on AQSE in June 2021, we set out a plan to develop revenue from a multi-retail strategy through three primary sources:
· Online sales
· Sales through third party stores
· Sales through our own stores
I am pleased to report that good progress was made on all business lines during the period. Online sales, which accounted for almost all of our revenue in May 2021, was in third place by the end of the period following the successful establishment of our two other sales channels - distribution and own retail stores. Today Voyager products are sold in stores throughout the
Since incorporation, the breakdown of our revenue across our three business lines has been well balanced with online sales accounting for 21%, our own stores (and sales at trade fairs) 37% and trade customers, as we would expect at this stage, leading with 42%. However, noting that our
Our pet products continue to attract considerable interest with our organic hemp seed oil for pets being our best-selling product by unit sales. We further expanded this range in September 2021 to include a hemp shampoo and odour neutraliser and we expect our pet range to continue to be a significant part of our revenue mix next year.
Within our core range, our peppermint CBD oil has overtaken our gummies as our best-selling edible product and the introduction of our CBD skincare line in September has opened new sales and distribution opportunities as we hoped it would, following a very successful trade fair in
We focus on the higher margin part of the industry, being formulations and branding, with all of our cultivation, extraction and manufacturing outsourced to others. The majority of our products are supplied by four manufacturers all of whom have proved to be reliable on quality and availability. We periodically explore alternative sources of supply but, at present, we do not expect to make any changes. It is particularly significant that, through the strength of our relationships with our suppliers, we have been able to develop new products on low production volumes and so preserving our working capital.
This strategy of outsourcing enables us to keep capital expenditure and working capital very low with no requirement to invest in factory premises or machinery. With the acreage of hemp growth increasing around the world and the continued investment by other businesses in extraction and manufacturing facilities, we expect wholesale pricing to remain under pressure and Voyager stands to be a beneficiary of this.
We continue to keep a tight rein on costs across all of our operations. The head office is based in a serviced office in
Our primary focus since the early part of the summer has been on developing a network of stores that stock our products, including opening our first Voyager stores in
As we have stated previously, our own store rollout has been supported by the development of an extensive product range of 32 formulated products and a total of 90 SKUs (stock keeping unit), along with a limited number of guest brands. Not only does this improve the shopping experience for its customers but it also enables the Company to stock products that are exclusive to its stores.
Following the opening of our store in
Like other businesses in the
There is a similar story on logistics and supplies with several deliveries of raw materials taking longer than expected. As with our comment on labour above, at present this has only been an inconvenience and we have factored into our plans longer lead times to ensure we remain fully stocked and able to supply our customers at all times. With Christmas approaching, in line with other retailers, we have expanded our inventories to see us through the holiday period. Our budgeting assumes that delivery and packaging costs will rise in 2022 but, as explained above, we anticipate this will be offset by falling wholesale prices of hemp.
During the summer we took the decision to purchase two Fiat Fiorino vans. The first was delivered in September and the second at the beginning of this month. Both vans are decorated with Voyager's logo and contact details and so provide mobile advertising as well as cost-effective transport for the team. In the first two months of using one van, we estimate that we have saved over
We have accomplished a great deal in our first year of operations. We have an extensive product range, a growing network of distribution contracts, three of our own stores, increasing brand recognition and a reinvigorated online strategy. With these building blocks in place, the onus is on us to continue to build our revenue. Based on our achievements so far, we are optimistic about the future.
Nick Tulloch
CEO
19 November 2021
Financial Review
Voyager is a
The Company was incorporated on 12 November 2020 and, on 30 June 2021, trading in its ordinary shares commenced on the Aquis Stock Exchange Growth Market. The comparatives reflect the 20-week period since incorporation on 12 November 2020 to 31 March 2021.
The Company achieved sales in the six-month period to 30 September 2021 of
Monthly overheads, which exclude all product manufacturing, marketing and delivery costs, were a little under
Since the period end, the Company opened a new store in
As stated above, five Voyager employees are supported by government grants and the Company recognises these as other income (being
The Company made a loss after tax for the period of
Voyager maintains a strong balance sheet with cash and inventory in excess of
Cash balances reflect the pre-payment of rent in
In spite of opening a large number of trade accounts in a short space of time, account management has been well organised and, to date, the Company has experienced no bad debts.
As a legacy of its founder investors subscription for shares, Voyager holds
In accordance with IFRS 16, with regard to accounting for leases, finance lease liabilities of
Outlook
With Voyager's existing product development plans largely finished for the time being, the Company's primary focus is now on revenue generation.
Objectives in the coming months include:
· Targeted social media and advertising campaigns following the relaunch and upgrade of Voyager's website. This includes the development of "landing pages" such as VoyagerPets.co.uk which was launched last week.
· Continued development of the Company's network of trade partners. Attendance at trade fairs and conferences will continue during 2022 with a focus on Voyager's target markets of health & wellness, beauty and pet care. The Company will also explore a limited number of advertising and partnership opportunities to continue to build its brand recognition, the first of which is a partnership with Murrayshall golf club in
· Ongoing development of its own stores. For the time being, Voyager will concentrate on developing the local markets around its
The Directors recognise that, although growing strongly, the CBD market in the
Unaudited Consolidated Statement of Comprehensive Income
for the six months ended 30 September 2021
|
|
6 months to 30 September 2021
£'000 |
Period ended 31 March 2021
£'000 |
|
|
|
|
|
Revenue |
59 |
6 |
|
Cost of sales |
(36) |
(4) |
|
Gross profit |
23 |
2 |
|
|
|
|
|
Operating expenses |
(340) |
(32) |
|
Other operating income |
4 |
- |
|
Operating loss |
(313) |
(30) |
|
|
|
|
|
Net finance expense |
(1) |
- |
|
Loss before tax |
(314) |
(30) |
|
|
|
|
|
Taxation due |
- |
- |
|
Loss after tax |
(314) |
(30) |
|
|
|
|
|
Earnings per share |
(3.69p) |
(2.62p) |
There was no other comprehensive income in the period. All activities relate to continuing operations.
Unaudited Consolidated Statement of Financial Position
at 30 September 2021
|
|
As at 30 September 2021
£'000 |
As at 31 March 2021
£'000 |
|
Non-current assets |
|
|
|
Fixed assets - company vans |
11 |
- |
|
Fixed assets - fixtures, fittings and equipment |
13 |
5 |
|
Fixed assets - right of use assets |
79 |
- |
|
Total non-current assets |
103 |
5 |
|
|
|
|
|
Current assets |
|
|
|
Inventory |
81 |
20 |
|
Debtors |
60 |
4 |
|
Cash at bank |
1,846 |
862 |
|
Total current assets |
1,987 |
886 |
|
|
|
|
|
Total assets |
2,090 |
891 |
|
|
|
|
|
Current liabilities |
|
|
|
Trade and other payables |
(48) |
(4) |
|
Lease liabilities |
(12) |
- |
|
Total current liabilities |
(60) |
(4) |
|
|
|
|
|
Non-current liabilities |
|
|
|
Lease liabilities |
(54) |
- |
|
|
|
|
|
Total liabilities |
(114) |
(4) |
|
|
|
|
|
Total net assets |
1,976 |
887 |
|
|
|
|
|
Capital and reserves attributable to equity holders of the Company |
|
|
|
Share capital |
93 |
9 |
|
Share premium |
1,431 |
494 |
|
Shares to be issued |
- |
414 |
|
Equity reserve |
46 |
- |
|
Retained earnings |
406 |
(30) |
|
|
|
|
|
Total shareholder funds |
1,976 |
887 |
Unaudited Consolidated Cash Flow Statement
for the six months ended 30 September 2021
|
|
|
6 months to 30 September 2021
£'000 |
Period ended 31 March 2021
£'000 |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
|
Loss before tax |
|
(314) |
(30) |
|
Adjustments for: |
|
|
|
|
Depreciation of fixtures, fittings and equipment |
|
2 |
1 |
|
Depreciation of right-of-use assets |
|
13 |
- |
|
Finance expense - interest on lease liabilities |
|
1 |
- |
|
Exchange rate gains |
|
(6) |
- |
|
Share based remuneration |
|
44 |
- |
|
|
|
(260) |
(29) |
|
|
|
|
|
|
Increase in trade and other receivables |
|
(56) |
(4) |
|
Increase in trade and other payables |
|
44 |
4 |
|
Increase in inventories |
|
(61) |
(10) |
|
Cash used in operations |
|
(333) |
(39) |
|
|
|
|
|
|
Investing activities |
|
|
|
|
Purchase of fixed assets - company vans |
|
(11) |
- |
|
Purchase of fixed assets - fixtures, fittings and equipment |
|
(10) |
(1) |
|
Net cash used in investing activities |
|
(21) |
(1) |
|
|
|
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
Repayment of principal - lease liabilities |
|
(25) |
- |
|
Repayment of interest - lease liabilities |
|
(1) |
- |
|
Proceeds from issue of shares, net of issue costs |
|
1,359 |
504 |
|
Receipt of funds for shares not yet issued |
|
- |
413 |
|
Net cash generated from financing activities |
|
1,333 |
917 |
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents |
|
979 |
877 |
|
Cash and cash equivalents at beginning of period |
|
861 |
- |
|
Exchange rate differences on cash and cash equivalents |
|
6 |
(16) |
|
Cash and cash equivalents and end of period |
|
1,846 |
861 |
|
|
|
|
|
Unaudited Consolidated Statement of Changes in Equity
for the six months ended 30 September 2021
|
|
|
Share Capital
£'000 |
Share Premium
£'000 |
Shares to be issued
£'000 |
Retained earnings
£'000 |
Total
£'000 |
|
|
|
|
|
|
|
|
|
Balance at incorporation |
|
- |
- |
- |
- |
- |
|
Issue of shares |
|
9 |
494 |
414 |
- |
917 |
|
Loss for the period |
|
- |
- |
- |
(30) |
(30) |
|
As at 31 March 2021 |
|
9 |
494 |
414 |
(30) |
887 |
|
|
Share capital
£'000 |
Share premium
£'000 |
Shares to be issued
£'000 |
Equity reserve
£'000 |
Retained earnings
£'000 |
Total
£'000 |
|
|
|
|
|
|
|
|
|
At 1 April 2021 |
9 |
494 |
414 |
- |
(30) |
887 |
|
Issue of shares |
84 |
1,689 |
(414) |
- |
- |
1,359 |
|
Reserves transfer |
- |
(750) |
- |
- |
750 |
- |
|
Share based remuneration |
- |
(2) |
- |
46 |
- |
44 |
|
Loss for the period |
- |
- |
- |
- |
(314) |
(314) |
|
As at 30 September 2021 |
93 |
1,431 |
- |
46 |
406 |
1,976 |
The following describes the nature and purpose of each reserve within equity:
|
Reserve |
Description and purpose |
|
Share capital |
Amount subscribed for share capital at the nominal value of |
|
Share premium |
Amount subscribed for share capital in excess of nominal value, net of share issue costs |
|
Shares to be issued |
Amounts received in respect of shares to be issued |
|
Equity reserve |
Amounts recognised for share-based payment transactions including share options granted to employees and other parties |
|
Retained earnings |
Cumulative net gains and losses recognised in the consolidated statement of comprehensive income |
Notes to the Interim Results
for the six months ended 30 September 2021
1. Basis of preparation
This announcement has been prepared in accordance with International Financial Reporting Standards, International Accounting Standards and Interpretations (collectively IFRS) issued by the International Accounting Standards Board (IASB) as adopted by the European Union ("adopted IFRS"), and with the Companies Act 2006 applicable to companies reporting under IFRS.
Going concern
The financial statements have been prepared on a going concern basis. In assessing whether the going concern assumption is appropriate, the Directors take into account all available information for the foreseeable future, in particular for the twelve months from the date of approval of the financial statements. This information includes management prepared cash flows forecasts, available sources of funding and considerations of the ongoing impact of COVID-19 on the business, its suppliers, its customers and how the global pandemic may impact product launches and sales.
The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the financial statements.
2. Profit/(loss) per share
Basic earnings per share is calculated by dividing the profit attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the year, excluding ordinary shares purchased by the Company and held as treasury shares.
The number of ordinary shares of
|
|
6 months to 30 September 2021 |
Period ended 31 March 2021
|
|
|
|
|
|
Weighted average number of ordinary shares in issue |
8,487,821 |
1,150,068 |
3. Segmental information
Revenue
All revenue arises from the retail of products for the health and wellness market as follows:
|
|
|
6 months to 30 September 2021
£'000 |
Period ended 31 March 2021
£'000 |
|
|
Revenue |
|
|
|
|
Trade customers |
27 |
- |
|
|
Voyager store - |
22 |
- |
|
|
Online sales |
8 |
6 |
|
|
Trade fairs |
2 |
- |
|
|
|
59 |
6 |
|
|
|
|
|
4. Share based payments
During the period to 30 September 2021, Voyager granted a total of 998,566 share options under its EMI share option plan (the "EMI Plan") to employees. The share options are exercisable at
Subsequent to the period end, on 11 October 2021, Voyager granted a further 70,800 share options under the "EMI Plan" to employees who joined the Company in the past three months. The share options are exercisable at
The total number of awards made under the EMI Plan are currently 1,069,366 representing 11.56% of the Company's issued share capital.
The results for the period include a share option cost, relating to the EMI plan of
5. Share capital and other reserves
As at 30 September 2021, the Company had in issue 9,252,920 ordinary shares of
· On 4 April 2021, the Company issued 2,844,165 new ordinary shares to existing shareholders pursuant to a 3 for 1 bonus issue.
· On 4 April 2021 and 8 April 2021, a total of 2,821,044 new ordinary shares were issued pursuant to the Company's crowdfunding raising
· On 23 April 2021, 1,950,000 new ordinary shares were issued pursuant to the Company's private funding raising
· On 30 June 2021, the Company issued 689,656 new ordinary shares pursuant to the Company's IPO raising
Other reserve movements in the period include:
· On 3 April 2021, a resolution was passed approving a reduction of capital whereby
· On 18 May 2021, the Company passed a special resolution for the Share Premium Reserve to be reduced by
6. Forward-looking statements
These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not a guarantee of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.
7. Other information
The financial information in this report does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006.
The interim results for the six months ended 30 September 2021 are unaudited. The interim financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRS) and International Financial Reporting Interpretations Committee (IFRIC) interpretations as endorsed by the European Union. The same accounting policies, presentation and methods of computation have been followed in the preparation of these results as were applied in the Company's audited financial statements dated 31 March 2021, as presented for the purpose of the Admission Document.
The Company will prepare its first audited Annual Report and Financial Statements for the period from incorporation to 31 March 2022.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.